Flavio Fazioli

Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Correction: Postsurgery fluids promote transition of cancer stem cell toendothelial and AKT/mTOR activity contributing to relapse of giant cell tumors of bone.

Correction: Postsurgery fluids promote transition of cancer stem cell toendothelial and AKT/mTOR activity contributing to relapse of giant cell tumors of bone.

Journal: Oncotarget
Published: June 09, 2026

Correction: Mosca et al. Sarcoma Common MHC-I Haplotype Restricts Tumor-Specific CD8+ T Cell Response. Cancers 2022, 14, 3414.

Correction: Mosca et al. Sarcoma Common MHC-I Haplotype Restricts Tumor-Specific CD8+ T Cell Response. Cancers 2022, 14, 3414.

Journal: Cancers
Published: December 25, 2025

Vasculogenic Mimicry: A Potential Therapeutic Target for Chondrosarcoma Therapy.

Vasculogenic Mimicry: A Potential Therapeutic Target for Chondrosarcoma Therapy.

Journal: Cells
Published: December 18, 2025

Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma.

Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma.

Journal: Cells
Published: April 30, 2024

Increasing differential diagnosis between lipoma and liposarcoma through radiomics: a narrative review.

Increasing differential diagnosis between lipoma and liposarcoma through radiomics: a narrative review.

Journal: Exploration of targeted anti-tumor therapy
Published: December 07, 2022

Sarcoma Common MHC-I Haplotype Restricts Tumor-Specific CD8+ T Cell Response.

Sarcoma Common MHC-I Haplotype Restricts Tumor-Specific CD8+ T Cell Response.

Journal: Cancers
Published: June 14, 2022

Crosstalk between Macrophages and Myxoid Liposarcoma Cells Increases Spreading and Invasiveness of Tumor Cells.

Crosstalk between Macrophages and Myxoid Liposarcoma Cells Increases Spreading and Invasiveness of Tumor Cells.

Journal: Cancers
Published: June 11, 2021

Lysosome purinergic receptor P2X4 regulates neoangiogenesis induced by microvesicles from sarcoma patients.

Lysosome purinergic receptor P2X4 regulates neoangiogenesis induced by microvesicles from sarcoma patients.

Journal: Cell death & disease
Published: April 02, 2021

Operating procedures for electrochemotherapy in bone metastases: Results from a multicenter prospective study on 102 patients.

Operating procedures for electrochemotherapy in bone metastases: Results from a multicenter prospective study on 102 patients.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: February 24, 2021

Is immunotherapy in the future of therapeutic management of sarcomas?

Is immunotherapy in the future of therapeutic management of sarcomas?

Journal: Journal of translational medicine
Published: January 25, 2021

Inhibiting Monocyte Recruitment to Prevent the Pro-Tumoral Activity of Tumor-Associated Macrophages in Chondrosarcoma.

Inhibiting Monocyte Recruitment to Prevent the Pro-Tumoral Activity of Tumor-Associated Macrophages in Chondrosarcoma.

Journal: Cells
Published: April 01, 2020

Patient-derived organoids as a potential model to predict response to PD-1/PD-L1 checkpoint inhibitors.

Patient-derived organoids as a potential model to predict response to PD-1/PD-L1 checkpoint inhibitors.

Journal: British journal of cancer
Published: May 31, 2019
Showing 1-12 of 27

Last Updated: 09/26/2026